I just had a short talk with Judy from IR
and this was basically my message to her.
They just spent 2 years working on Appeals Manager and the new oil & gas software.
I told her that in my mind no ones spends that much time developing a product, without having a very good idea how large the market is for that product. I asked her if they know how large the market is and she said yes they do.
I further stated that I bet they had a number in mind of how big a % of that market could be theirs and I suggested that the company release those numbers to the public. It would be an excellent way prior to FINs for all to get a sense of what the value of the company could be.
She agreed that it sounded like a good idea and she would bring it up to Mr Allen and see about getting this into a press release. Releasing numbers resulting from a market study the company has run prior to developing these products could hardly be construed as pumping the stock.. and in fact is just putting out what I would think any shareholder would want to know and has a right know.
Any biotech I have traded, I first look at the size of the market for their drug they are developing as usually told by the company, and what percentage they hope to grab. I can then get an idea using the O/S whether the stock is low, where it should be, or too high.
I hope anyone else that talks to the company puts it to them just that way..Whats the estimated market size for the products you have?
I cant think of any good reason not share that info and I think the 2 segments they are both in, are both gigantic. Unpaid Insurance claims I bet run into 100s of millions of dollars in this country..And JCDS with their partner get 25% of all claims they process.
